Devices and Endoscopic Bariatric Therapies for Obesity.
Curr Obes Rep
; 7(2): 162-171, 2018 Jun.
Article
en En
| MEDLINE
| ID: mdl-29667157
ABSTRACT
PURPOSE OF REVIEW In this review, we describe the FDA-approved and investigational devices and endoscopic bariatric therapies for the treatment of obesity. We focus on literature published in the past few years and present mechanisms of action as well as efficacy and safety data. RECENT FINDINGS:
Devices and endoscopic procedures are emerging options to fill the significant treatment gap in the management of obesity. Not only are these devices and procedures minimally invasive and reversible, but they are potentially more effective than antiobesity medications, often safer for poor surgical candidates and possibly less expensive than bariatric surgery. As many patients require a variety of management strategies (medications, devices, procedures, and/or surgery) in addition to lifestyle modifications to achieve clinically significant weight loss, the future of obesity treatment involves a multidisciplinary approach. Combinations of advanced treatment strategies can lead to additive or synergistic weight loss. This is an area that requires further investigation.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Obesidad Mórbida
/
Endoscopía
/
Cirugía Bariátrica
/
Medicina Bariátrica
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Curr Obes Rep
Año:
2018
Tipo del documento:
Article
País de afiliación:
Estados Unidos